Compare Chemclin vs Genomic Health
Customers evaluate the quality of Chemclin's products using the following success metrics.
Overview
Chemclin is 25 yrs old and is based in China.
Chemclin (SHG: 688468) engages in vitro diagnostic chemiluminescence. It is a Chinese technical service provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. Its service covers clinical inspection instruments, auxiliary reagents (chemiluminescence, biochemical, exemption), technical services, management and certification, independent medical laboratories, and more. The company is dedicated to the introduction of diagnostic products and services to the market. It was founded in 1999 and is based in Beijing, China.
Genomic Health is 24 yrs old and is based in United States.
Genomic Health is a life science company. It focuses on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It was founded in 2000 and is based in Redwood City, California. In July 2019, Genomic Health was acquired by Exact Sciences.
Demo Video
Leadership
Lin Li (President)
Gene Early (Founder)
Investors
Actis Capital, HighLight Capital
Exact Sciences, Kleiner Perkins Caufield & Byers
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Chemclin has not claimed their profile.
Work for Chemclin? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Chemclin?
Claim your profile now.
Information not available because Genomic Health has not claimed their profile.
Work for Genomic Health? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Genomic Health?
Claim your profile now.